Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FendX Technologies Inc C.FNDX

Alternate Symbol(s):  FDXTF

FendX Technologies Inc. is a Canada-based nanotechnology company engaged in developing surface protection coatings. The Company is focused on developing products to reduce the spread of pathogens. The Company is developing both film and spray products to protect surfaces from contamination. The lead product under development, REPELWRAP film, is a protective surface coating film that, due to its repelling properties, prevents the adhesion of pathogens and reduces their transmission on surfaces prone to contamination. The spray nanotechnology is a bifunctional spray coating being developed to reduce contamination on surfaces by repelling and killing pathogens. The Company is conducting research and development activities using its nanotechnology in collaboration with partners, including McMaster University. The Company has worldwide licenses for its technology and IP portfolio from McMaster, which encompass both film and spray coating nanotechnology formulations.


CSE:FNDX - Post by User

Post by 1StockInformeron May 04, 2023 7:35pm
162 Views
Post# 35431560

Emerging health care tech opportunities post COVID - FNDX

Emerging health care tech opportunities post COVID - FNDX

Given the ongoing global impact of COVID-19, there is a heightened awareness of the potential for future pandemics or epidemics. As a result, there is a growing demand for products that can effectively mitigate the transmission of viruses and bacteria. FendX Technologies Inc. (FNDX.C) is developing advanced solutions using proprietary nanotechnology that can prevent pathogen transmission.


One of the main things that position FNDX for success within the healthcare product market is its highly experienced leadership. FNDX's CEO has experience creating and growing healthcare businesses. She is a Principal at BioEnsemble LLC, where she works with small pharma companies and start-ups to develop business strategies. Additionally, FNDX's COO has done sales and marketing for leading pharmaceutical and biotechnology corporations in Canada. 


FNDX's flagship product is REPELWRAP™ film, a coating that can be adhered to surfaces to make bacteria and viruses bounce off of them. Because REPELWRAP™ does not kill pathogens like disinfectants, its use is not expected to contribute to antibiotic resistance or create superbugs. 


With its impressive leadership and technology, FNDX is well-positioned to meet the rising demand for pathogen-preventing products when it launches REPELWRAP™ film in 2024.


User image


More information here: https://fendxtech.com  Posted on behalf of FendX Technologies Inc.

 
<< Previous
Bullboard Posts
Next >>